{
  "ptid_time": "032_S_6804_2019-09-24",
  "img_path": "/data/qiuhui/data/adni/images/032_S_6804/2019-09-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 47,078 mm³, 56.8% above the reference mean. With a Z-score of 1.35 (91.1th percentile), this represents mild enlargement; hippocampal volume measures 7,040 mm³, 12.3% below the reference mean. With a Z-score of -1.23 (11.0th percentile), this represents mild atrophy; whole brain volume measures 1,033,510 mm³, 8.9% below the reference mean. With a Z-score of -1.26 (10.4th percentile), this represents mild atrophy; entorhinal cortex volume measures 5,009 mm³, 17.5% above the reference mean. With a Z-score of 1.21 (88.7th percentile), this represents mild enlargement; fusiform gyrus volume measures 21,753 mm³, 9.3% above the reference mean. With a Z-score of 0.77 (77.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,118 mm³, 5.8% below the reference mean. With a Z-score of -0.48 (31.7th percentile), this represents normal volume . ",
  "text_data": "Age is 69.1 years. Gender is Male. Education: 16 years. MMSE: 25.0. MoCA: 26.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.37 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild hippocampal and whole brain atrophy, along with ventricular enlargement, which are structural changes often associated with Alzheimer's disease (AD). However, the MMSE (25) and MoCA (26) scores are borderline but not strongly indicative of dementia, and the absence of APOE4 reduces genetic risk. Elevated AV45 (amyloid PET) suggests amyloid pathology, supporting AD-related changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **Medium** (due to borderline cognitive scores but clear structural and amyloid abnormalities)",
  "timestamp": "2025-07-26T05:09:39.193933"
}